Ind-Swift Laboratories informs about outcome of board meeting

07 Nov 2023 Evaluate
Ind-Swift Laboratories has informed that the Board of Directors of the Company in their meeting held today, 7th November, 2023, have considered and approved the Standalone and Consolidated Un-audited Financial Results of Ind-Swift Laboratories for the quarter and half year ended 30th September, 2023. These Financial Results are subject to limited review. The Limited Review Report as submitted by the Statutory Auditors is also enclosed along with the Unaudited Financial Results. The un-audited financial results of the Company will also be available on the website of the Company, www.indswiftlabs.com. The Board Meeting commenced at 01:00 PM and concluded at 03:45 PM.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

83.56 1.05 (1.27%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...